MAPT and Alzheimer disease: The adjustment of our statistical models for core AD biomarkers (Aβ42, P-tau) despite using them as inclusion criteria for the present analysis reflects our attempt to handle the idea that binary cutoffs must necessarily be used in patient workflows, but for prognostic modeling, it is best to use continuous biomarker values.